-
Description
-
Table of Contents
-
Table of Figures
-
Related Reports
PDF Download
-
Description
-
Table of Contents
-
Table of Figures
-
Related Reports
- PDF Download
Description
The global market for Emphysema Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Chronic obstructive pulmonary disease (COPD) is kind of lung disease which happen due to chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Emphysema Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Emphysema Treatment.
The Emphysema Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Emphysema Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Emphysema Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
Report Metric
Details
Report Title
Global Emphysema Treatment Market Research Report 2025
Global Emphysema Treatment Companies Covered
Pulmonx, Bioxyne, Intrexon, Icure Pharmaceuticals, Kamada, Emphasys Medical, Pfizer, Olympus, BTG, PneumRx and Uptake Medical, Halozyme Therapeutics, Mariposa Health, Uptake Medical
Global Emphysema Treatment Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Emphysema Treatment Market, Segment by Type
Global Emphysema Treatment Market, Segment by Application
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Emphysema Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Table of Figures
List of Tables
Table 1. Global Emphysema Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Centrilobular emphysema
Table 3. Key Players of Panlobular emphysema
Table 4. Global Emphysema Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Emphysema Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Emphysema Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Emphysema Treatment Market Share by Region (2020-2025)
Table 8. Global Emphysema Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Emphysema Treatment Market Share by Region (2026-2031)
Table 10. Emphysema Treatment Market Trends
Table 11. Emphysema Treatment Market Drivers
Table 12. Emphysema Treatment Market Challenges
Table 13. Emphysema Treatment Market Restraints
Table 14. Global Emphysema Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Emphysema Treatment Market Share by Players (2020-2025)
Table 16. Global Top Emphysema Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emphysema Treatment as of 2024)
Table 17. Ranking of Global Top Emphysema Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Emphysema Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Emphysema Treatment, Headquarters and Area Served
Table 20. Global Key Players of Emphysema Treatment, Product and Application
Table 21. Global Key Players of Emphysema Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Emphysema Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Emphysema Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Emphysema Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Emphysema Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Emphysema Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Emphysema Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Emphysema Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Emphysema Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Emphysema Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Emphysema Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Emphysema Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Emphysema Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Emphysema Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Emphysema Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Emphysema Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Emphysema Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Emphysema Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Emphysema Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Emphysema Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Emphysema Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Emphysema Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Emphysema Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Emphysema Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pulmonx Company Details
Table 47. Pulmonx Business Overview
Table 48. Pulmonx Emphysema Treatment Product
Table 49. Pulmonx Revenue in Emphysema Treatment Business (2020-2025) & (US$ Million)
Table 50. Pulmonx Recent Development
Table 51. Bioxyne Company Details
Table 52. Bioxyne Business Overview
Table 53. Bioxyne Emphysema Treatment Product
Table 54. Bioxyne Revenue in Emphysema Treatment Business (2020-2025) & (US$ Million)
Table 55. Bioxyne Recent Development
Table 56. Intrexon Company Details
Table 57. Intrexon Business Overview
Table 58. Intrexon Emphysema Treatment Product
Table 59. Intrexon Revenue in Emphysema Treatment Business (2020-2025) & (US$ Million)
Table 60. Intrexon Recent Development
Table 61. Icure Pharmaceuticals Company Details
Table 62. Icure Pharmaceuticals Business Overview
Table 63. Icure Pharmaceuticals Emphysema Treatment Product
Table 64. Icure Pharmaceuticals Revenue in Emphysema Treatment Business (2020-2025) & (US$ Million)
Table 65. Icure Pharmaceuticals Recent Development
Table 66. Kamada Company Details
Table 67. Kamada Business Overview
Table 68. Kamada Emphysema Treatment Product
Table 69. Kamada Revenue in Emphysema Treatment Business (2020-2025) & (US$ Million)
Table 70. Kamada Recent Development
Table 71. Emphasys Medical Company Details
Table 72. Emphasys Medical Business Overview
Table 73. Emphasys Medical Emphysema Treatment Product
Table 74. Emphasys Medical Revenue in Emphysema Treatment Business (2020-2025) & (US$ Million)
Table 75. Emphasys Medical Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Emphysema Treatment Product
Table 79. Pfizer Revenue in Emphysema Treatment Business (2020-2025) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Olympus Company Details
Table 82. Olympus Business Overview
Table 83. Olympus Emphysema Treatment Product
Table 84. Olympus Revenue in Emphysema Treatment Business (2020-2025) & (US$ Million)
Table 85. Olympus Recent Development
Table 86. BTG Company Details
Table 87. BTG Business Overview
Table 88. BTG Emphysema Treatment Product
Table 89. BTG Revenue in Emphysema Treatment Business (2020-2025) & (US$ Million)
Table 90. BTG Recent Development
Table 91. PneumRx and Uptake Medical Company Details
Table 92. PneumRx and Uptake Medical Business Overview
Table 93. PneumRx and Uptake Medical Emphysema Treatment Product
Table 94. PneumRx and Uptake Medical Revenue in Emphysema Treatment Business (2020-2025) & (US$ Million)
Table 95. PneumRx and Uptake Medical Recent Development
Table 96. Halozyme Therapeutics Company Details
Table 97. Halozyme Therapeutics Business Overview
Table 98. Halozyme Therapeutics Emphysema Treatment Product
Table 99. Halozyme Therapeutics Revenue in Emphysema Treatment Business (2020-2025) & (US$ Million)
Table 100. Halozyme Therapeutics Recent Development
Table 101. Mariposa Health Company Details
Table 102. Mariposa Health Business Overview
Table 103. Mariposa Health Emphysema Treatment Product
Table 104. Mariposa Health Revenue in Emphysema Treatment Business (2020-2025) & (US$ Million)
Table 105. Mariposa Health Recent Development
Table 106. Uptake Medical Company Details
Table 107. Uptake Medical Business Overview
Table 108. Uptake Medical Emphysema Treatment Product
Table 109. Uptake Medical Revenue in Emphysema Treatment Business (2020-2025) & (US$ Million)
Table 110. Uptake Medical Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Emphysema Treatment Picture
Figure 2. Global Emphysema Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Emphysema Treatment Market Share by Type: 2024 VS 2031
Figure 4. Centrilobular emphysema Features
Figure 5. Panlobular emphysema Features
Figure 6. Global Emphysema Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Emphysema Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinics Case Studies
Figure 10. Surgical center Case Studies
Figure 11. Emphysema Treatment Report Years Considered
Figure 12. Global Emphysema Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Emphysema Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Emphysema Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Emphysema Treatment Market Share by Players in 2024
Figure 16. Global Top Emphysema Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emphysema Treatment as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Emphysema Treatment Revenue in 2024
Figure 18. North America Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Emphysema Treatment Market Share by Country (2020-2031)
Figure 20. United States Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Emphysema Treatment Market Share by Country (2020-2031)
Figure 24. Germany Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Emphysema Treatment Market Share by Region (2020-2031)
Figure 32. China Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Emphysema Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Emphysema Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Emphysema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Pulmonx Revenue Growth Rate in Emphysema Treatment Business (2020-2025)
Figure 48. Bioxyne Revenue Growth Rate in Emphysema Treatment Business (2020-2025)
Figure 49. Intrexon Revenue Growth Rate in Emphysema Treatment Business (2020-2025)
Figure 50. Icure Pharmaceuticals Revenue Growth Rate in Emphysema Treatment Business (2020-2025)
Figure 51. Kamada Revenue Growth Rate in Emphysema Treatment Business (2020-2025)
Figure 52. Emphasys Medical Revenue Growth Rate in Emphysema Treatment Business (2020-2025)
Figure 53. Pfizer Revenue Growth Rate in Emphysema Treatment Business (2020-2025)
Figure 54. Olympus Revenue Growth Rate in Emphysema Treatment Business (2020-2025)
Figure 55. BTG Revenue Growth Rate in Emphysema Treatment Business (2020-2025)
Figure 56. PneumRx and Uptake Medical Revenue Growth Rate in Emphysema Treatment Business (2020-2025)
Figure 57. Halozyme Therapeutics Revenue Growth Rate in Emphysema Treatment Business (2020-2025)
Figure 58. Mariposa Health Revenue Growth Rate in Emphysema Treatment Business (2020-2025)
Figure 59. Uptake Medical Revenue Growth Rate in Emphysema Treatment Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Description
The global market for Emphysema Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Chronic obstructive pulmonary disease (COPD) is kind of lung disease which happen due to chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Emphysema Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Emphysema Treatment.
The Emphysema Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Emphysema Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Emphysema Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Emphysema Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Related Reports
-
The global Emphysema Treatment Medication market size was US$ 4266 million in 2024 and is forecast to a readjusted size of US$ 5331 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 110
USD 4250.00
(Single User License)
-
The global market for Emphysema Treatment Medication was estimated to be worth US$ 4266 million in 2024 and is forecast to a readjusted size of US$ 5331 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 131
USD 3950.00
(Single User License)
-
The global market for Emphysema Treatment Medication was valued at US$ 4266 million in the year 2024 and is projected to reach a revised size of US$ 5331 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published: 2025-03-12
Pages: 100
USD 2900.00
(Single User License)
-
The global market for Emphysema Treatment was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-26
Pages: 104
USD 3950.00
(Single User License)
-
Chronic obstructive pulmonary disease (COPD) is kind of lung disease which happen due to chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.
Published: 2024-04-24
Pages: 131
USD 4900.00
(Single User License)
-
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
Published: 2024-04-21
Pages: 94
USD 2900.00
(Single User License)
-
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
Published: 2024-04-21
Pages: 133
USD 4350.00
(Single User License)
-
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
Published: 2024-04-21
Pages: 157
USD 4900.00
(Single User License)
-
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
Published: 2024-04-21
Pages: 129
USD 3950.00
(Single User License)
-
Chronic obstructive pulmonary disease (COPD) is kind of lung disease which happen due to chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.
Published: 2024-01-23
Pages: 179
USD 3950.00
(Single User License)
0
